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Introduction 
Platypnea-orthodeoxia syndrome (P-Os) is a rare cause of dys-
pnea and is characterized by dyspnea while in an upright position.1-3) 
Platypnea means that dyspnea is induced by an upright posture 
and is relieved by adopting a recumbent position. And orthodeoxia 
means an arterial desaturation resulting from orthostatic condi-
tions.3)4) Although the exact mechanisms are not yet known, possi-
ble causes include three categories; intracardiac shunting, pulmo-
nary arteriovenous shunts or ventilation/perfusion mismatch in 
the lungs.5)6) Patent foramen ovale (PFO) is the most common cause 
among intracardiac shunt groups, followed by atrial septal defect 
(ASD) and fenestrated atrial septal aneurysm.6) Herein we report a 
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case of a patient with P-Os caused by ASD with normal right atrial 
pressure. To the best of our knowledge, this is the first case in Korea 
of successful treatment with a device closure in an ASD patient pre-
senting with P-Os. 
Case
A 29-year-old female was referred to our institute with symptom-
atic hypoxemia with one-week duration in April 2013. Her dyspnea 
was aggravated while sitting or standing and relieved while in su-
pine position. She had experienced intermittent dyspnea on exer-
tion since school age, but she had not been evaluated until this visit. 
She had been suffering from intermittent migraines with visual aura 
since 1998 and had been treated with intermittent analgesics since 
then. The brain magnetic resonance imaging taken in 2008 showed 
normal results. She had neither a history of hypertension, diabetes 
mellitus or pulmonary disease nor a family history of pulmonary or 
cardiovascular disease. The pulse oximetry showed a saturation of 
92% in a supine position, but this declined to 77% within one min-
ute after standing indoors at atmospheric pressure. Recovery of the 
hypoxemia was not sufficient, as 94% was reached in a supine po-
sition and 82% was reached within one minute after standing de-
spite supplemental oxygen therapy (100% oxygen, delivered via 
facemask). Her blood pressure was 107/69 mm Hg, her pulse rate 
was 72 beats per minute and her body temperature was 36.5°C. A 
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grade III systolic cardiac murmur was heard on the left upper ster-
nal border, the electrocardiogram (ECG) showed a sinus rhythm with 
premature ventricular complexes (PVC) and RSr’ pattern in V 1 (Fig. 1). 
The lung sound was clear and chest X-ray (Fig. 2) and spirometer 
were both normal, so there was no apparent pulmonary disease that 
could explain the dyspnea. A transthoracic echocardiography (TTE) 
showed an 8-mm-sized ASD with a right-side volume overload and 
a left-to-right shunt through ASD. There was a trivial tricuspid re-
gurgitation with peak pressure gradient of 22 mm Hg. Although 
the TTE image was interrupted by a poor echo window, the coronary 
arteries showed a normal pattern. The contrast-enhanced comput-
ed tomography (CT) showed no pulmonary thromboembolism, pul-
monary arteriovenous fistula or lung parenchymal disease. A 12-
mm sized ASD and mild kyphoscoliosis were evident in the CT. The 
ASD shown on TTE and the heart CT could not explain the patient’s 
dyspnea, so a cardiac catheterization was performed to evaluate 
the presence of pulmonary hypertension or a right-to-left shunt le-
sion, which would be masked on TTE or CT. The cardiac catheteriza-
tion showed a normal pulmonary artery pressure and a normal right 
atrial pressure (Table 1). A 34-mm-sized ASD was seen by the in-
tracardiac echocardiogram. The size of the ASD had been underes-
timated, possibly due to the poor echo window by TEE and transient 
bidirectional shunt by CT. During catheterization, a Valsalva ma-
neuver was performed that showed a bidirectional shunt via ASD 
Fig. 1. Twelve-lead electrocardiography. The electrocardiography shows premature ventricular complexes and RSr’ pattern in V 1.
Fig. 2. Chest X-ray on admission. A chest X-ray radiography showed no 
pulmonary lesion and no cardiomegaly (cardio-thoracic ratio was 48%).
Table 1. Results of cardiac catheterization
Pressure
Saturation
Pre Post
SVC 57%
RA 15/6/9 mm Hg 71%
RV 25/10 mm Hg
IVC 58%
PA 20/5/10 mm Hg 79%
LA 15/6/9 mm Hg
LV 110/10 mm Hg
AO 110/60 mm Hg 93%/79%* 96%†
Qp 3.04 L/min
Qs 1.48 L/min
Qp/Qs 2.08
L-R shunt 1.80 L/min
R-L shunt 0.24 L/min
RA, PA and LA data were expressed as a wave/v wave/mean pressure. *The 
patients’ arteial oxygen saturation was decreased from 93% while in su-
pine position to 79% while at a 15° sitting position, †The arterial oxygen 
saturation after closure was also improved to 96%. To avoid complications, 
positional change was not perfomed. AO, RV and LV data were expressed as 
systolic/end-diastolic pressure. SVC: superior vena cava, RA: right atrium, RV: 
right ventricle, IVC: inferior vena cava, PA: pulmonary artery, LA: left atrium, 
LV: left ventricle, AO: aorta, Qp: pulmonary blood flow, Qs: systemic blood 
flow, L-R: left to right, R-L: right to left 
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(Fig. 3) and the patients’ arterial oxygen saturation decreased from 
93% while in supine position to 79% while at a 15° sitting position. 
Finally, she was diagnosed as suffering from ASD with P-Os. An 
ASD device closure with an Amplatzer® septal occluder (36 mm, St. 
Jude Medical, Golden Valley, MN, USA) was successfully done under 
intracardiac echocardiogram guidance (Fig. 4), which resulted in 
the disappearance of both platypnea and orthodeoxia immediately 
after the procedure. The arterial oxygen saturation after closure was 
also improved to 96%. The patient has been free of symptoms for 
one year of follow-up and a recent TTE performed in April 2014 
showed normal findings, including no residual ASD shunt. 
A Holter monitoring was performed before catheterization and 
revealed 22% of PVCs. The patient was treated with oral propranolol, 
but it was discontinued soon due to symptomatic bradycardia. She 
has been free from symptoms such as palpitation for one year and 
the latest ECG performed in June 2014 showed a normal sinus 
rhythm. During her hospitalization, the patient complained of mi-
graine headaches with visual aura three times a week and was treat-
ed with topiramate 25 mg twice daily. The brain magnetic resonance 
imaging and the angiography performed to check for cryptogenic 
stroke related to migraines, which would be due to a paradoxical 
embolism, showed no abnormalities in the brain parenchyma or in-
tracranial and neck vessels. The migraine headache disappeared by 
three months after the ASD device closure and did not recur for 
one year, despite stopping taking topiramate six months after the 
ASD device closure. 
Discussion
Platypnea-orthodeoxia syndrome is a rare clinical syndrome that 
A  B  C  
Fig. 3. Intracardiac echocardiography. A: an ICE showed an underestimated large ASD. B: the Doppler imaging showed a left-to-right shunt through an 
ASD. C: however, a bidirectional shunt occurred with Valsalva maneuver. ICE: intracardiac echocardiography, ASD: atrial septal defect, LA: left atrium, RA: 
right atrium. 
A  B  
Fig. 4. A large ASD was treated with Amplatzer® (St. Jude Medical) septal occluder. A large ASD was measured by the balloon occlusion method (A) and 
successfully treated with 36-mm sized Amplatzer® (St. Jude Medical) septal occluder (B). Her symptoms were resolved immediately after the procedure. 
ASD: atrial septal defect.
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is characterized by dyspnea while in an upright position. Three 
causes are possible: intracardiac shunts, pulmonary arteriovenous 
shunts or ventilation/perfusion mismatches in the lungs. Pulmonary 
arteriovenous shunts are usually located in the lung bases; increased 
flow in the lung base while in an upright position may increase the 
shunt, causing aggravated dyspnea and hypoxemia. A ventilation/
perfusion mismatch would explain the mechanism of P-Os in some 
groups: hepatopulmonary syndrome, amiodarone toxicity, auto-
nomic dysfunction and lung parenchymal disease such as emphy-
sema.6) A failure to accommodate the gravitational blood flow chang-
es due to an impaired pulmonary vascular tone while in an upright 
position, especially in the basal alveoli, is a possible mechanism in 
the former three groups. When standing upright, the right ventricu-
lar preload decreases, resulting in a decreased output to the pulmo-
nary arteries, so that the alveolar pressures exceed the arterial and 
venous pressures.6) Moreover, a decreased blood flow at the apex 
due to gravity makes apical areas act as dead space while in an up-
right position. This phenomenon would explain the mechanism of 
P-Os in a lung parenchymal disease. Intracardiac P-Os are associated 
with the interatrial communication: PFO is most common, followed 
by ASD secundum, atrial septal aneurysm7) and ASD ostium primum. 
In this situation, the right-to-left shunt can be caused when the 
right side pressure is elevated or when the heart–lung anatomy is 
distorted and the venous blood is redirected towards the interatrial 
communication. An elevated right atrial pressure is usually linked to 
a decreased right ventricular compliance, but is sometimes related 
with pulmonary arterial hypertension. This etiology group includes 
pulmonary embolism,8) constrictive pericarditis,9) pericardial effu-
sion,10) and right ventricular myocardial infarction.11) Anatomical dis-
tortions include aortic dilatation, aortic elongation12) and persistent 
Eustachian valve. Other causes of anatomical distortion are right 
pneumonectomy, kyphoscoliosis4) and phrenic palsy. The present pa-
tient was diagnosed as having P-Os caused by ASD and being af-
fected by kyphoscoliosis. She was successfully treated by transcath-
eter device closure with an Amplatzer® septal occluder (St. Jude 
Medical), which resulted in the resolution of both platypnea and 
orthodeoxia immediately after the procedure. Interestingly, she had 
been suffering from migraine headaches with visual aura for sev-
eral years, which then disappeared three months after device clo-
sure. There is a well-known relationship between PFO and migraines 
and that the treatment of PFO would reduce or eliminate migraine 
headache is estabilished.13) The relationship between ASD and mi-
graine was not well established. However, according to Mortelmans 
et al.,14) a percutaneous ASD closure was not related to a decrease 
in the prevalence of migraine. Nevertheless, in the subgroup of pa-
tients who suffered from typical migraines before ASD closure, the 
frequency of migraine attacks decreased significantly. Luermans et 
al.’s15) findings supported this relationship in a prospective study. 
P-Os is a rare and complex clinical disease entity that must be con-
sidered in the differential diagnosis of unexplained postural hypox-
emia, and it is important to pay attention to the pattern of dyspnea. 
Many patients may not be correctly diagnosed due to routine ex-
amination with an ECG, chest roentgenogram or even with TTE, as 
in our case. 
The diagnosis of cardiac P-Os consists of the demonstration of 
the presence of a right-to-left shunt and the documentation of an 
orthodeoxia with either pulse oximetry or blood gas analysis. A con-
trast TTE may demonstrate this phenomenon, but a contrast trans-
esophageal echocardiography in both a supine and upright position 
is the preferable choice for diagnosis. Recently, a percutaneous de-
vice closure has been considered as a treatment of choice for car-
diac P-Os, since this approach has proven to be safe, reliable and 
effective.16) Before considering a percutaneous closure, a cardiac 
catheterization is required with a complete evaluation of oxygen 
saturation and pressure. As in our case, the size difference of ASD 
should be evaluated during Valsalvar maneuver and it is crucial to 
select the proper sized device in the transcatheter closure of ASD.
In conclusion, P-Os should be considered in the differential diag-
nosis in patients with unexplained hypoxemia. Herein, we present 
the first Korean case of transcatheter treatment of ASD presented 
with platypnea and orthodeoxia, and discuss the pattern of dyspnea, 
diagnostic approach and the mechanisms of intracardiac P-Os. 
Lastly, this case highlights the importance of a complete evaluation 
with cardiac catheterization and careful percutaneous closure.
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